Skip directly to search Skip directly to A to Z list Skip directly to page options Skip directly to site content

Figure E. Secondary Antibiotic Used to Treat Gonorrhea among GISP Participants

This web page is archived for historical purposes and is no longer being updated.

CLINIC% of cases
Doxy/TetAzi/EryNone/Other
ALBUQUERQUE0.799.3.
ATLANTA.98.91.1
BALTIMORE68.531.5.
BIRMINGHAM79.416.64.1
CHICAGO3.795.90.4
CLEVELAND4.096.0.
COLUMBUS0.993.85.3
DALLAS1.198.20.7
DENVER57.642.4.
GREENSBORO.95.94.1
HONOLULU.97.92.1
KANSAS CITY0.398.01.7
LAS VEGAS.100.0.
LOS ANGELES0.791.97.4
MIAMI65.433.01.6
MINNEAPOLIS1.398.7.
NEW ORLEANS1.598.5.
NEW YORK CITY3.990.55.6
OKLAHOMA CITY94.31.54.1
ORANGE COUNTY.92.67.4
PHILADELPHIA0.797.91.4
PHOENIX0.399.30.3
PONTIAC0.597.42.1
PORTLAND.99.10.9
RICHMOND.95.05.0
SAN DIEGO.99.01.0
SAN FRANCISCO1.697.70.8
SEATTLE.89.910.1
TRIPLER.100.0.

Top